In vitro vascularization improves in vivo functionality of human engineered cardiac tissues
Acta Biomaterialia · 2026-02 · 211 · 61-73
DOI: 10.1016/j.actbio.2024.11.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-02. Verfasst von Hanjun Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIBIB NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Engineered human cardiac tissues hold great promise for disease modeling, drug development, and regenerative therapy. For regenerative applications, successful engineered tissue engraftment in vivo requires rapid vascularization and blood perfusion post-implantation. In the present study, we engineered highly functional, vascularized cardiac tissues ("cardiopatches") by co-culturing human induced pluripotent stem cell-derived cardiomyocytes (hiPSCCMs) and endothelial cells (hiPSC-ECs) in optimized serum-free media. The vascularized cardiopatches displayed stable capillary networks over 4 weeks of culture, the longest reported in the field, while maintaining high contractile stress (>15 mN/mm2) and fast conduction velocity (>20 cm/s). Robustness of the method was confirmed using two distinct hiPSC-EC sources. Upon implantation into dorsal-skinfold chambers in immunocompromised mice, in vitro vascularized cardiopatches exhibited improved angiogenesis compared to avascular implants. Significant lumenization of the engineered human vasculature and anastomosis with host mouse vessels yielded the formation of hybrid human-mouse capillaries and robust cardiopatch perfusion by blood. Moreover, compared to avascular tissues, the implanted vascularized cardiopatches exhibited significantly higher conduction velocity and Ca2+ transient amplitude, longitudinally monitored in live mice for the first time. Overall, we demonstrate successful 4-week vascularization of engineered human cardiac tissues without loss of function in vitro, which promotes tissue functionality upon implantation in vivo. STATEMENT OF SIGNIFICANCE: Complex interactions between cardiac muscle fibers and surrounding capillaries are critical for everyday function of the heart. Tissue engineering is a powerful method to recreate functional cardiac muscle and its vascular network, which are both lost during a heart attack. Our study demonstrates in vitro engineering of dense capillary networks within highly functional engineered heart tissues that successfully maintain the structure, electrical, and mechanical function long-term. In mice, human capillaries from these engineered tissues integrate with host mouse capillaries to allow blood perfusion and support improved implant function. In the future, the developed vascularized engineered heart tissues will be used for in vitro studies of cardiac development and disease and as a potential regenerative therapy for heart attack.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
- Department of Radiation Oncology, Cancer Biology Division at Duke University Medical Center, Duke University, NC 27708, USA.
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA. Electronic address: nbursac@duke.edu.
Förderung
- NIGMS NIH HHS
- NIBIB NIH HHS
- NHLBI NIH HHS
- National Science Foundation
- National Science Foundation Graduate Research Fellowship Program
- National Institutes of Health
Zitieren
APA
Li, H., Shadrin, I., Helfer, A., Heman, K., Rao, L., Curtis, C., Palmer, G. M., & Bursac, N. (2026). In vitro vascularization improves in vivo functionality of human engineered cardiac tissues. Acta Biomaterialia, 211, 61-73. https://doi.org/10.1016/j.actbio.2024.11.014
Vancouver
Li H, Shadrin I, Helfer A, Heman K, Rao L, Curtis C, et al. In vitro vascularization improves in vivo functionality of human engineered cardiac tissues. Acta Biomaterialia. 2026;211:61-73. doi:10.1016/j.actbio.2024.11.014
BibTeX
@article{Li2026,
author = {Li, Hanjun and Shadrin, Ilya and Helfer, Abbigail and Heman, Karen and Rao, Lingjun and Curtis, Caroline and Palmer, Gregory M and Bursac, Nenad},
title = {In vitro vascularization improves in vivo functionality of human engineered cardiac tissues},
journal = {Acta Biomaterialia},
year = {2026},
volume = {211},
pages = {61--73},
doi = {10.1016/j.actbio.2024.11.014}
}
EUVIMED